EUKARYOTIC CELL, Oct. 2008, p. 1819â€“1830                                                                                         Vol. 7,  10
1535-9778/08/$08.00â«¹0 doi:10.1128/EC.00088-08
Copyright Â© 2008, American Society Microbiology. Rights Reserved.



             TOR1 TOR2 Distinct Locations Live CellsäŒ¤â€ 
                Thomas W. Sturgill,1* Adiel Cohen,2 Melanie Diefenbacher,2 Mark Trautwein,2
                                 Dietmar E. Martin,2 Michael N. Hall2
            Department Pharmacology, University Virginia Health Sciences Center, Charlottesville, Virginia 22908,1
                               Biozentrum, University Basel, CH-4056 Basel, Switzerland2
                                                Received 11 March 2008/Accepted 9 July 2008

             TOR structurally functionally conserved Ser/Thr kinase multiprotein complexes           regulate cellular processes control cell growth. extensively studied, localization TOR
          ambiguous, possibly endogenous TOR live cells examined.  examined
          localization green fluorescent protein (GFP) tagged, endogenous TOR1 TOR2 live S. cerevisiae
          cells. DNA cassette encoding copies green fluorescent protein (3XGFP) inserted TOR1
          gene  codon D330) TOR2 gene  codon N321). TORs tagged internally TOR1           TOR2 tagged N C terminus functional. TOR1D330-3XGFP strain hypersensitive           rapamycin, cold sensitive, resistant manganese toxicity caused loss Pmr1,           indications TOR1-3XGFP expressed functional. TOR2-3XGFP functional, TOR2           essential gene TOR2N321-3XGFP haploid cells viable.  TOR1 TOR2 retain function           insertion 748 amino acids variable region noncatalytic domain. localization patterns           TOR1-3XGFP TOR2-3XGFP documented imaging live cells. TOR1-3XGFP diffusely
          cytoplasmic concentrated near vacuolar membrane. TOR2-3XGFP signal cytoplasmic           predominately dots plasma membrane.  TOR1 TOR2 distinct localization patterns,
          consistent regulation cellular processes different complexes.


   TOR (target rapamycin) large (â¬ƒ2,500 amino acids),                  localized surface vacuolar membrane using
highly conserved protein kinase controls cell growth                   antibody raised sequence TOR2 (5). Subsequently,
response nutrients. Saccharomyces cerevisiae,                  [35S]TOR1 [35S]TOR2 P13 P100 highly related TOR proteins, TOR1 TOR2 (11).                      membrane fractions (21). P13 fraction enriched proteins associate membranes partially resistant                  plasma membrane (PM), endoplasmic reticulum (ER), vacu- extraction Triton X-100 (3, 21). TOR                   oles, mitochondria, P100 fraction enriched
structurally functionally distinct multiprotein complexes,                 Golgi bodies, endosomes, secretory vesicles. TOR1 TORC1 TORC2 (41). TORC1 contains TOR1 TOR2                              TOR2 P13 fraction fractionated equilib- Kog1, Tco89, Lst8. TORC2 contains TOR2, Avo1,                          rium sucrose gradients similarly Pma1, PM marker. Avo2, Avo3, Bit61, Lst8. TORC1 TORC2                          TORs distinct, unidentified membrane
essential, TORC1 inhibited rapamycin. TORC1                     pool. revealed immunofluorescence, overexpressed hem-
controls growth-related processes, including transcrip-                agglutinin-tagged TOR1 TOR2 localized discrete sites
tion, translation, ribosome biogenesis, nutrient transport,                â€œdotsâ€? just beneath PM (21). immunogold
autophagy. TORC2 controls different set processes,                     electron microscopy, Wedaman et al. identified hemagglutinin-
cluding actin organization, endocytosis, lipid biosynthesis                tagged TOR2 adjacent PM intracellular mem-
(4). TORCs, components, key role cell                   branous tracks (40). recent biochemical study, TORC2
growth conserved yeast human. major                        components Avo3 TOR2 correlated best early
unanswered question TOR regulates processes,                    endosome marker (Rsv5), TORC1 components 
directly indirectly.                                                        lapped diffusely trans-Golgi, ER, vacuolar markers
   potential source diversity biologic processes                (3). Li et al. reported immunostaining study TOR1 TOR regulation subcellular localization TOR.                   predominantly nuclear exported cytoplasm TOR signaling depend colocalization TOR                     response rapamycin treatment nutrient starvation (24).
key substrates involved different cellular functions differ-              localization TOR ambiguous, possibly ent times define branches TOR signaling. localization                previous studies relied fixed fractionated cells. TOR1 TOR2 cells studied biochemical                       visualize localization functional, internally
fractionation immunostaining. early study, TOR2                      green fluorescent protein (GFP)-tagged TOR1 TOR2                                                                                live cells. localization patterns TOR1-3XGFP
   * Corresponding author. Mailing address: Department Pharma-              (TOR1 tagged DNA cassette encoding copies cology, Box 800735, Room 5045, Jordan Hall, University Virginia             GFP) TOR2-3XGFP (TOR2 DNA cassette encoding
Health Sciences Center, Charlottesville, VA 22908. Phone: (434) 924-           copies GFP) distinct complex, possibly account-
1919. Fax: (434) 924-5207. E-mail: Thomas_Sturgill@virginia.edu.
   â€  Supplemental material article http://ec
                                                                               ing heretofore ambiguity TOR localization. 
.asm.org/.                                                                      various localization patterns TORs underlie
   äŒ¤
     Published ahead print 22 August 2008.                               control different cellular processes.

                                                                        1819
 1820         STURGILL ET AL.                                                                                                                           EUKARYOT. CELL


                                        TABLE 1. Primers 3XGFP tagging TOR1 TOR2 using pOM3
         Primer                                 Target                                                            Sequence (5â¬˜ 3â¬˜ 
TOR1-N-Fwd                                  N terminus                           GGTAAAGTGAAACATACATCAACCGGCTAGCAGGTTTGCATTGAT
                                                                                  ATG TGC AGG TCG ACA ACC CTT AAT
TOR1-N-Rev                                  N terminus                           CGCTTTCAAAAGTTTACTCTTCCAAATCTGCTCCTCATGCGGTTC
                                                                                  GCG GCC GCA TAG GCC ACT
TOR1-D67-Fwd                                D67                                  TGACTTCTAGTAGGTTTGATGGAGTGGTGATTGGCAGTAATGGG
                                                                                  TGC AGG TCG ACA ACC CTT AAT
TOR1-D67-Rev                                D67                                  GGTTAATTCGCGGAAAATTTTCTCCAAAATGGGCTTAAAATTTAC
                                                                                  GCG GCC GCA TAG GCC ACT
TOR1-D330-Fwd                               D330                                 ATCCATGCAAGTTTGTTGGTTTATAAGGAAATCTTGTTTTTGAAG
                                                                                  TGC AGG TCG ACA ACC CTT AAT
TOR1-D330-Rev                               D330                                 TATGCAATTTAGACACATTTGGTCGAACACTTGATTCAAAAAGGG
                                                                                  GCG GCC GCA TAG GCC ACT
TOR2-N-Fwd                                  N terminus                           TCTTTCTCAAAGAGATTTCTGATCTTTACTTTCCCCATATGAAAA
                                                                                  ATG TGC AGG TCG ACA ACC CTT AAT
TOR2-N-Rev                                  N terminus                           AGACAATAAGTTAGGTGGCGTGGTGTATTTGTTAATGTATTTATT
                                                                                  GCG GCC GCA TAG GCC ACT
TOR2-N321-Fwd                               N321                                 CAAAGATTATTTCAAGGTTGTACACATGGCTTAAGTCTCAATACG
                                                                                  TGC AGG TCG ACA ACC CTT AAT
TOR2-N321-Rev                               N321                                 GCTGAGTAATTCTCGAAATACCAACAGAGTAGCATGCACTGAATC
                                                                                  GCG GCC GCA TAG GCC ACT
      underlined portion sequence TOR1 TOR2. italicized portion ATG codon added primer replace initiating ATG codon.
Sequence italicized underlined sequence pOM3 template.



                         MATERIALS METHODS                                          nonrepeated kanMX6 ORF. TOR1/Fwd/â«º500, expected prod-
                                                                                        ucts observed 9/15 colonies tested N-terminal tagging (741 nucleo-
   Yeast media. Rich medium (YPD) synthetic medium (SD SC)                                                                                         tides [nt]), 8/15 tested D67 tagging (942 nt), 11/16 tested D330 tagging
prepared described previously (35). Rapamycin added YPD medium dilutions 1-mg/ml stock 90  ethanol-10  Tween 20 just               (1,731 nt), TOR2/Fwd/â«º486, expected product (727 nt) ob-
plates poured.                                                                     served 2/2 colonies.
   Strains 3XGFP inserted TOR1 TOR2. sequence 3XGFP                Cells taken cultures liquid YPD transformed pSH47 S65G mutation optimized expression yeast amplified              lithium acetate-polyethylene glycol lower-efficiency, simplified method, pBS-3XGFP-TRP1 (22) primers MT101 (5â¬˜-CCCGATATCGGAGGATCC                           transformants selected SD-uracil (SD-ura) plates (secondary colo-
ATGTCTAAAGGT-3â¬˜) MT102 (5â¬˜-GGACTAGTTTTGTACAATT                                      nies). Plasmid pSH47 introduces Gal-inducible Cre 5-fluoroorotic acid
CATCCATACCAT-3â¬˜) cloned EcoRV SpeI sites pUG6                 removable plasmid. Tiny amounts single colonies inoculated 4 ml restriction, creating pOM3. constructed 3XGFP strains described previ-            SC-ura containing 1  galactose 1  raffinose 15-ml disposable tubes.
ously using pOM3, minor modifications (15). strategy uses kanMX6             induction 5 h (30Â°C), cells collected centrifugation, resus-
resistance marker select recombinants later removed Cre            pended small residual volume, streaked obtain single colonies
combinase, restoring open reading frame (ORF) gene containing           YPD plates. tertiary colonies identified, circled labeled, repeated tag. specific TOR primers used amplify 3.8-kb cassette         streaked YPD plates YPD plates containing G418 test excision pOM3 given Table 1. Portions PCRs used transform haploid          kanMX6 Gal-induced Cre. convention, example, TOR1N-15-6-1, TB50a  TOR1) diploid TB50a/â?£  TOR2) strains high-efficiency            helpful indicate gene site followed single colony numbers  lithium acetate-polyethylene glycol method. Transformants allowed            primary [G418], secondary [SD-ura], tertiary [YPD] colonies 
cover 4 6 h YPD plated YPD plates containing G418.            troduction Cre). tertiary colonies lost kanMX6 marker Single colonies streaked YPD plates allowed grow 30Â°C,            studied 
plates stored 4Â°C primary isolates.                                         Validation TOR1-3XGFP strains. TOR2-3XGFP strains verified    TOR1 ORF disrupted stop codon kanMX6 marker               described later text. TOR1-3XGFP strains verified follows. 
removal Cre recombinase (15). primers used characterization           combination integrate 3XGFP cassette confirmed colony PCR strains listed Table 2. Colonies tested integration correct   primers TOR1 sequences outside cassette. PCR primers TOR1/
site colony PCR Cre step, using reverse primer (kanMX6/Rev)           Fwd/â«º72 TOR1/Rev/â«¹280 (Table 2) gave 2,599-nt band diagnostic 


                                                      TABLE 2. Primers used characterization strains
         Primer                                                    Locationa                                                                Sequence

TOR1/Fwd/â«º500                                   Promoter, â«º500 â«º480                                                 5â¬˜-AGACAGCAAACCACCTGTTGC-3â¬˜
TOR1/Fwd/â«º72                                    Promoter, â«º72 â«º53                                                   5â¬˜-CCATAGTAGCTTCACGAGAG-3â¬˜
TOR1/Fwd/â«¹801                                   ORF, 801 821                                                        5â¬˜-GGTGATCAGAATTGATGCGTC-3â¬˜
TOR1/Rev/â«¹280                                   ORF, 258 280                                                        5â¬˜-TACTGGCCAATTTTCGTTCCTCC-3â¬˜
TOR1/Rev/â«¹1101                                  ORF, 1080 1101                                                      5â¬˜-TGCTAATAGGGGAACAATCTGG-3â¬˜
TOR2/Fwd/â«º486                                   Promoter, â«º486 â«º464                                                 5â¬˜-CGTCATTTTTTACATACTGCTGC-3â¬˜
TOR2/Fwd/â«¹711                                   ORF, 711 730                                                        5â¬˜-ATACAGGAGACATGCTGCGC-3â¬˜
TOR2/Fwd/â«¹931                                   ORF, 931 951                                                        5â¬˜-TTTCAAGGTTGTACACATGGC-3â¬˜
TOR2/Rev/â«¹990                                   ORF, 970 990                                                        5â¬˜-CAGAGTAGCATGCACTGAATC-3â¬˜
kanMX6/Rev                                      3XGFP cassette                                                         5â¬˜-CCGTGCGGCCATCAAAATG-3â¬˜
GFP/Rev                                         3XGFP cassette, 165 185  Cre)                                 5â¬˜-GCATCACCTTCACCTTCACCG-3â¬˜
        Location nt ATG start codon specified.
 VOL. 7, 2008                                                                                                    TOR1-3XGFP TOR2-3XGFP                          1821


                                                             TABLE 3. Yeast strains plasmids
Strain plasmid                                                    Genotype description                                                      Reference source

 Strains
   TB50a                    MATa leu2-3,112 ura3-52 rme1 trp1 his3 HMLa                                                                             Hall collection
   TB50a/â?£                  MATa/â?£ leu2-3,112/leu2-3,112 ura3-52/ura3-52 rme1/rme1 trp1/trp1 his3/his3 HMLa/HMLa                                    Hall collection
   JK9-3da/â?£                MATa/â?£ leu2-3,112/leu2-3,112 ura3-52/ura3-52 rme1/rme1 trp1/trp1 his4/his4 HMLa/HMLa                                    Hall collection
   AN9-2a                   MATa leu2-3,112 ura3-52 rme1 trp1 his3 tor1::kanMX6 HMLa
   LJ25-1A                  MATa leu2-3,112 ura3-52 rme1 trp1 his3 pmr1âŒ¬::kanMX4 HMLa                                                               10
   LJ25-2C                  MATâ?£ leu2-3,112 ura3-52 rme1 trp1 his3 pmr1âŒ¬::kanMX4 HMLa                                                               10
   VA19                     MATa leu2-3,112 ura3-52 rme1 trp1 his3 KOG18XGFP::URA3 HMLa                                                               study
   VA33                     MATa leu2-3,112 ura3-52 rme1 trp1 his3 TOR1D330-3XGFP HMLa/pSH47 å…³CEN URA3å…´                                               study
   VA34                     MATa leu2-3,112 ura3-52 rme1 trp1 his3 TOR1D330-3XGFP HMLa/pSH47 å…³CEN URA3å…´                                               study
   VA35                     MATa leu2-3,112 ura3-52 rme1 trp1 his3 TOR1D330-3XGFP HMLa/pSH47 å…³CEN URA3å…´                                               study
   VA36                     MATa leu2-3,112 ura3-52 rme1 trp1 his3 TOR1D67-3XGFP HMLa/pSH47 å…³CEN URA3å…´                                                study
   VA38                     MATa leu2-3,112 ura3-52 rme1 trp1 his3 TOR1D67-3XGFP HMLa/pSH47 å…³CEN URA3å…´                                                study
   VA41                     MATa leu2-3,112 ura3-52 rme1 trp1 his3 TOR1N-3XGFP HMLa/pSH47 å…³CEN URA3å…´                                                  study
   VA43                     MATa/â?£ leu2-3,112/leu2-3,112 ura3-52/ura3-52 rme1/rme1 trp1/trp1 his3/his3 TOR2N321-3XGFP/                                study
                             TOR2 HMLa/HMLa
    VA66                    MATa leu2-3,112 ura3-52 rme1 trp1 his3 TOR1D330-3XGFP HMLa                                                                study
    VA68-9c                 MATa leu2-3,112 ura3-52 rme1 trp1 his3 TOR1D330-3XGFP HMLa/pSH47 å…³CEN URA3å…´                                               study
    VA68-9c                 MATa leu2-3,112 ura3-52 rme1 trp1 his3 pmr1âŒ¬::kanMX4 TOR1D330-3XGFP HMLa                                                  study
    YGD25                   MATa leu2-3,112 ura3-52 rme1 trp1 his3 tor1âŒ¬::LEU2-4 pmr1âŒ¬::kanMX4 HMLa                                                 9
    VA86                    MATa leu2-3,112 ura3-52 rme1 trp1 his3 TOR2N321-3XGFP HMLa/pSH47 å…³CEN URA3å…´                                               study
    VA102                   MATa leu2-3,112 ura3-52 rme1 trp1 his3 TOR2N321-3XGFP HMLa                                                                study
    VA109                   MATa leu2-3,112 ura3-52 rme1 trp1 his3 OG18XGFP::URA3 HMLa                                                                study
    VA121                   MATa leu2-3,112 ura3-52 rme1 trp1 his3 TOR2N321-3XGFP KOG18XGFP::URA3 HMLa                                                study
    YGD25                   MATa leu2-3,112 ura3-52 rme1 trp1 his3 tor1âŒ¬::LEU2-4 pmr1âŒ¬::kanMX4 HMLa                                                 9

 Plasmids
   pSH47                    pGAL-cre å…³CEN URA3å…´                                                                                                     16
   pTA19                    Integrating plasmid KOG1 (nt 3000â€“4671)-8XGFP:URA3                                                                      2
   pTPQ128                  pADH1-Sec7-dsRed å…³CEN LEU2å…´                                                                                             31
   pTPQ127                  pGPD1-FYVE-dsRed å…³CEN LEU2å…´                                                                                             31




3XGFP colony TOR1/D67-1-1-1, strain VA38 (Table 3). PCR            TOR1-3XGFP, VA109 (constructed similarly VA19 TB50â?£) set gave expected 2,602-nt band expected 3XGFP            crossed VA66 desired segregant (VA121) chosen.
colony TOR1N-15-6-1, strain VA41 (Table 3). PCR TOR1/Fwd/â«¹801                 Spottings growth assays. Strains grown overnight liquid YPD (5-ml
TOR1/Rev/â«¹1101 gave expected 2,548-nt band diagnostic 3XGFP            culture), collected centrifugation, washed water, 0.1 ml TOR1/D330-14-1-6 14-1-3, strains VA34 VA35, respectively,             used inoculate SD (5 ml) overnight. Cells adjusted concentration larger â¬ƒ3.4-kb band TOR1/D330-3-1-2, strain VA33.                               optical density 600 nm 1.0, serially diluted 1:10 96 plate,    second proof, repeated PCR primer specific GFP     transferred plates pinning device.
pOM3. Using TOR1/Fwd/â«º72 GFP/Rev, bands corresponding                 FM4-64 staining. Cells grown YPD A600 0.8. Cells (20 40
expected 456-, 1,176-, 1,896-nt products 3XGFP insertion clearly   A600 units mlâ«º1 YPD medium) incubated ice 30 min 30 â?®mol
present strain VA38 (Table 3). VA34 confirmed observation        literâ«º1 FM4-64 dye (Molecular Probes ), washed YPD, incu-
expected 372-, 1,092-, 1,896-products using TOR1/Fwd/â«¹801 GFP/           bated 60 min steady-state experiments described previously (38).
Rev. PCR VA38 TOR1/Fwd/â«º72 GFP/Rev gave expected                    Microscopy. Cells imaged log phase, immobilization 260- 980-nt products 1,700-nt product VA38, prefer-       slides coated concanavalin  Microscopy 3XGFP strains ential amplification smaller products.                                           performed Zeiss Axioplan 2 microscope equipped MRm camera
   final proof, correct integration confirmed sequenc-   (Carl Zeiss, Aalen Oberkochen, Germany) Plan Apochromat 63â«»/1.40-
ing. Genomic DNA purified cell breakage phenol-chloroform            numerical-aperture objective oil. Zeiss Axiovision 3.1 software used method amplified PCR TOR1/Fwd/â«¹801  VA34 VA35),                 control filters acquire images field chosen differential
TOR1/Fwd/â«º72  VA34 VA41), GFP/Rev. band priming                interference contrast (DIC). Exposure settings GFP different figures varied GFP purified sequenced. VA33 VA34/VA35            800 2,000 ms noted; comparisons intensity independent primary colonies.                                                       valid figures figures. Images analyzed Axiovi-
   Isolation proteins Western blot analysis. crude supernatant protein     sion software (Zeiss), equal adjustments images (control 3XGFP
(1,500 â«» g 1 min) isolated method using glass beads breakage   strains) taken experiment. Axiovision files exported TIFF format cells. lysis buffer ice-cold phosphate-buffered saline, 10  glycerol,    cropped Photoshop modification brightness contrast. 0.5  Tween 20 inhibitors (1.25 â?®g/ml leupeptin, 0.75 â?®g/ml antipain,       confocal imaging, used Olympus 1X81 spinning-disk microscope 0.25 â?®g/ml chymotrypsin, 0.25 â?®g/ml elastinol, 5 â?®g/ml pepstatin, 1 mM phen-        Plan Apochromat 60â«»/1.42-numerical-aperture oil objective, used IQ
ylmethylsulfonyl fluoride, 1 mM EDTA). Protein (40 â?®g), sodium dodecyl           Andor software collect deconvolute stack images. Deconvoluted images
sulfate sample buffer, loaded 7.5  sodium dodecyl sulfate-polyacryl-       exported ImageJ Photoshop.
amide gel electrophoresis gel used Western blot analysis (6). mixture mouse monoclonal antibodies (clones 7.1 13.1) GFP (Roche
Applied Science) used dilution 1:1,000. antibody detection (ECL kit) Amersham.                                                                                          RESULTS
   Kog1-8XGFP strains. Plasmid pTA19 contains portion (3,000 4,671 nt) KOG1/LAS24 ORF HindIII XbaI sites p8XGFPIU (2). TB50a
                                                                                      Identification region TOR1 internal 3XGFP tag- transformed SalI-treated pTA19, generating strain VA19 colony        ging. Visualization low-abundance proteins, TORs,
selection SD-ura (Table 3). generate strains Kog1-GFP           requires incorporation multiple tags. incor-
 1822     STURGILL ET AL.                                                                                                     EUKARYOT. CELL




   FIG. 1. alignment evolutionary divergent species identifies region TOR insertion 3XGFP. Proteins aligned ClustalW (7). relevant portion shown. Residues D67 D330 TOR1 N321 TOR2 indicated asterisks. Arrows indicate
sites 3XGFP inserted D330 (TOR1) N321 (TOR2) retention function. Humans, Caenorhabditis elegans, Cryptococcus
neoformans TOR. Default colors alignment parameters implementation ClustalW (7) http://npsa-pbil.ibcp.fr/.




poration multiple copies N terminus           TOR2N-3XGFP, respectively) nonfunctional  Fig. 5 C terminus protein question.             8). TOR contains multiple subdomains, experience (data shown), TOR1 TOR2                   fully characterized important interactions
tolerate fusion tag N C terminus.              conserved components TOR complexes. reasoned
Consistent previous observations, TOR1 TOR2                internal region permissive insertion 3XGFP 3XGFP N terminus (encoded TOR1N-3XGFP                  revealed comparison evolutionary divergent
 VOL. 7, 2008                                                                                             TOR1-3XGFP TOR2-3XGFP                   1823




   FIG. 2. TOR2-3XGFP expressed, TOR1D330-3XGFP strains normal sensitivity rapamycin.   Western blot anti-GFP antibodies 40 â?®g total protein  Materials Methods) control (Ctl), TB50a, VA34 strains. indicated strains streaked YPD (B), YPD plus 1 nM
rapamycin (Rap) (C), YPD plus 2 nM rapamycin (D). Cells grown 2 days 30Â°C streaking scanned.



TOR proteins. identify candidate region insertion 3XGFP, aligned TOR proteins (viz., human mTOR
[mammalian TOR], Saccharomyces cerevisiae TOR1 TOR2,
Schizosaccharomyces pombe Tor2, Caenorhabditis elegans TOR, Cryptococcus neoformans TOR) (Fig. 1). variable
region near D330 noncatalytic domain S. cerevisiae
TOR1. region TORs contains natural inser-
tions, D330 TOR1 viewed potentially permis-
sive insertion 3XGFP. test hypothesis, gen-
erated independent strains (VA33, VA34, VA35), contain frame cassette encoding 3XGFP replacing
D330 TOR1  Materials Methods Table 3). 3XGFP insertion shown alignments Fig. S1 supplemental material. used different phenotypic tests determine functionality new TOR1D330-3XGFP allele
encoding TOR1-3XGFP, described directly 
   TOR1-3XGFP encoded TOR1D330-3XGFP functional.
TOR1-3XGFP expressed intact protein apparent mass greater 250 kDa (Fig. 2A). phenotype loss TOR1 rapamycin hypersensitivity. Rapa-
mycin hypersensitivity tor1âŒ¬ cells specific loss TOR1 function point mutations inactivate
TOR1 kinase activity cause hypersensitivity low 
centration (1 nM) rapamycin (33). independent
strains TOR1D330-3XGFP hypersensitive 1 nM 2 nM rapamycin (Fig. 2B C) grew equivalently absence rapamycin (Fig. 2A), indicating TOR1-
3XGFP expressed functional. higher concentra-
                                                                                   FIG. 3. TOR1D330-3XGFP strains adapt cold stress. indicated
tion rapamycin (5 nM) nearly completely inhibited                        strains streaked YPD   YPD plus 2 nM rapamycin
growth TOR1D330-3XGFP TOR1 strains ex-                            (Rap) (B) Cells grown 4 days 15Â°C (15 deg C) pected (data shown).                                                        streaking scanned.
 1824     STURGILL ET AL.                                                                                               EUKARYOT. CELL


         YPD
                                   TOR1,
                                   PMR1


        TOR1D330-3XGFP,                           tor1âˆ†,
        PMR1                                      PMR1



        TOR1D330-3XGFP,                           tor1âˆ†,
        pmr1âˆ†                                     pmr1âˆ†



                                   TOR1,
                                   pmr1âˆ†

        B. YPD + 2 mM Mn2+
                                TOR1,
                                PMR1


        TOR1D330-3XGFP,                           tor1âˆ†,
        PMR1                                      PMR1


                                                                       FIG. 5. TOR1D67-3XGFP partially functional.   Growth YPD
        TOR1D330-3XGFP,                           tor1âˆ†,            containing 1 nM rapamycin. indicated strains (Table 3)         pmr1âˆ†                                     pmr1âˆ†             streaked, 3 days growth, plate scanned. Growth
                                                                    patterns YPD streaks experiment similar
                                                                    (data shown). (B) Growth 15Â°C (15 deg) YPD YPD plus
                                TOR1,                               1 nM rapamycin (Rap). indicated strains assayed 10-fold
                                pmr1âˆ†                               dilution pinning; TOR1D67-3XGFP (VA38) used. plates
                                                                    scanned 4 days.
  FIG. 4. TOR1D330-3XGFP, like TOR1, sensitive Mn2â«¹ pmr1âŒ¬ strain. indicated strains streaked YPD   YPD containing 2 mM Mn2â«¹ (final concentration) (B). Cells grown 2 days 30Â°C, plates scanned. TOR1    N terminus TOR1, significantly PMR1 (TB50a), tor1âŒ¬ PMR1 (AN9-2a), tor1âŒ¬ pmr1âŒ¬ (YGD25),             divergence sequence D330 (Fig. 1). Notably, TOR1
TOR1 pmr1âŒ¬ (LJ25-1A), TOR1D330-3XGFP pmr1âŒ¬ (VA68-9c),                                                                     functional 2XMyc higher numbers Myc pro-
TOR1D330-3XGFP PMR1 (VA34) strains used (Table 3).
                                                                    teins, placed residues 86 87 N-terminal
                                                                    segment (27;  Lorberg, personal communication).                                                                     TOR1D67-3XGFP partially functional    loss TOR1 causes cold-sensitive growth defect (Fig.     conferred partial resistance 1 nM rapamycin (Fig. 5A).
3). Adaptation cold stress rescued kinase-defec-     function TOR1D67-3XGFP greater tive TOR1 (data shown). TOR1D330-3XGFP strains         TOR1N-3XGFP, reflected rapamycin cold sensitivity
cold sensitive (Fig. 3A). fact, TOR1D330-3XGFP strains grew      corresponding strains. TOR1D330-3XGFP strain somewhat better 15Â°C wild type. enhanced           functional growth presence rapamycin growth potential TOR1D330-3XGFP strains 15Â°C         15Â°C TOR1N-3XGFP TOR1D67-3XGFP strain
observed presence 2 nM rapamycin (Fig. 3B).          (Fig. 5B).
result shows Tor1D330-3XGFP expressed func-        Kog1 essential protein binds TOR1 TOR2 tional adaptation cold stress requires active TOR1       TORC1 (27). Strains containing Kog1 3XGFP 8XGFP
kinase activity.                                                    incorporated C terminus genomic tags viable (2,
   Pmr1 P-type ATPase localizes predominantly          37). confirmed KOG1C-8XGFP cells (VA19) Golgi bodies transports Ca2â«¹ Mn2â«¹ lumen             hypersensitive 1 nM rapamycin (Fig. 5B). cytoplasm (13). Pmr1 function important Ca2â«¹           TOR1-3XGFP diffusely cytoplasmic concentrated regulation secretory pathway removal          discrete sites near vacuolar membranes. TOR1-3XGFP 
toxic levels Mn2â«¹. TOR1 genetic interaction           coded TOR1D330-3XGFP visualized live cells. cells
pmr1âŒ¬ (9). pmr1âŒ¬ strain does grow presence 2        grown rich medium (YPD), TOR1-3XGFP dispersed
mM Mn2â«¹, growth rescued loss TOR1.        cytoplasm concentrated near vac- TOR1D330-3XGFP pmr1âŒ¬ strain sensitive Mn2â«¹     uolar membrane, dot (Fig. 6). TOR1-3XGFP
TOR1 pmr1âŒ¬ strain (Fig. 4).  assayed separate      observed, rarely, dots near plasma
phenotypic tests, TOR1-3XGFP encoded TOR1D330-3XGFP           membrane (data shown). vacuole (Fig. 6A) iden-
functional like wild-type TOR1.                                     tified autofluorescence contents red wavelengths
   comparison insertion D330,             morphology DIC. Vacuolar autofluorescence structed 3XGFP strains targeted residue D67, nearer         prominent cells grown rich medium
 VOL. 7, 2008                                                                                  TOR1-3XGFP TOR2-3XGFP               1825




  FIG. 6. TOR1D330-3XGFP predominantly cytoplasmic concentrated dots near vacuolar membrane.   Localization TOR1-3XGFP cells grown YDP. Merged GFP (green; GFP channel) autofluorescence images TB50a (control) lacking GFP
cassette TOR1-3XGFP (VA34) strains shown. Strains grown overnight YPD, diluted, imaged log phase centrifugation suspension synthetic medium. arrow indicates dot near vacuole, feathered arrow indicates dot near vacuolar membrane. (B) TOR1-3XGFP signal overlaps FM4-64 staining  Materials Methods) vacuolar membrane.
Control, strain TB50a lacking GFP cassette; TOR1-3XGFP, strain VA102. exposure settings used follows: DIC, 300 ms; GFP,
10,000 ms; Fm4-64 (Cy3), 10,000 ms.



(YPD). confirmed perivacuolar localization               contains guanine-nucleotide exchange activity Arf
TOR1-3XGFP signal comparing FM4-64,             proteins involved Golgi function (8). Sec7-dsRed marker
specifically stains vacuolar membrane steady state (Fig.        trans-Golgi (28). localization TOR1-3XGFP 6B) (38). portion TOR1-3XGFP overlapped                  qualitatively different Sec7-dsRed.  Sec7-
expected ring-like staining FM4-64 marking vacuolar             dsRed vesicles numerous dots TOR1-
membrane.                                                              3XGFP, second, punctate signals TOR1-3XGFP
   predominant localization KOG1-GFP vac-                (Fig. 7) did exactly correspond. closer correspondence
uolar membrane reported previously (2, 37).                observed TOR1-3XGFP FYVE-dsRed
compared TOR1-3XGFP Kog1-GFP strains strain                   marker.
containing GFP fusions (VA121)  Fig. S2                   FYVE-dsRed fusion protein binds phosphatidylino-
supplemental material). perivacuolar signal GFP                                                                        sitol-3-phosphate  review, reference 23) double-GFP strain dramatically increased  Fig.
                                                                       generally marker early endosomes S2 supplemental material) compared                                                                        near vacuole. FYVE-dsRed localizes  punctate struc-
single-GFP strain. TOR2-3XGFP, studied comparison,
                                                                       tures adjacent vacuole, weakly vacuole-limiting
did perivacuolar localization  Fig. S2 supplemental material).                                                membrane, cases vacuoleâ€? (18).    localization TOR1-3XGFP compared              emphasize description TOR1-3XGFP localiza-
Sec7-dsRed FYVE-dsRed (Fig. 7) (31). Cells grown            tion similar description regard vacu-
selective synthetic medium maintain plasmid encoding            ole. TOR1-3XGFP appeared localize near  dsRed marker. Sec7 high-molecular-weight protein               FYVE-dsRed punctate structures near  1826     STURGILL ET AL.                                                                                                EUKARYOT. CELL




  FIG. 7. TOR1D330-3XGFP localization distinct Sec7-dsRed similar FYVE-dsRed. performed microscopy following strains SD SD-leu  : TB50a (control strain, SD), TOR1D330-3XGFP (V66, SD), TOR1D330-3XGFP plus
FYVE-dsRed (VA66 transformed pTPQ127, SD-leu), TOR1D330-3XGFP plus Sec7-dsRed (VA66 transformed pTPQ128, SD-leu). arrow shows example colocalization TOR1D330-3XGFP FYVE domain marker punctate structure. exposure
settings used follows: DIC, 100 ms; GFP, 2,000 ms; dsRed, 500 ms.



vacuole.  TOR1-3XGFP localization distinct                candidate complete 3XGFP cassette prin- FYVE-dsRed localization TOR1-3XGFP                   cipal product â¬ƒ2.3-kb band chosen diffusely cytoplasmic dot-like concen-           study  VA102). candidates 2XGFP
trations TOR1-3XGFP near vacuole.                   1XGFP. TOR2-3XGFP VA102 expressed â¬Ž250-
  TOR2 functional 3XGFP inserted replace                kDa protein Western blotting anti-GFP antibodies
N321. success TOR1D330-3XGFP encouraged                (Fig. 8C). results demonstrate TOR2 
generate GFP fusion alleles TOR2 (Fig. 8). targeted             mains functional despite insertion 3XGFP N321 N terminus residue N321 TOR2. Like D330                 TOR2 3XGFP N terminus nonfunc-
TOR1, N321 TOR2 corresponds variable region                tional. noncatalytic domain TOR2. TOR2-targeted                       TOR2-3XGFP localizes punctate structures near 3XGFP cassette introduced diploid strains            plasma membrane. localization TOR2-3XGFP  
TOR2 essential. assess functionality GFP             coded TOR2N321-3XGFP VA102) compared fusion proteins, diploids containing desired TOR2N-3XGFP       Sec7-dsRed FYVE-dsRed conditions similar TOR2N321-3XGFP allele sporulated, dissected, ger-            used TOR1-3XGFP (Fig. 9). TOR2-3XGFP did minated. TOR2N-3XGFP allele nonfunctional                  colocalize Sec7-dsRed FYVE-dsRed, cause spores viable 13/13 tetrads dissected          TOR2-3XGFP concentrated near vacuolar
 Fig. S3 supplemental material). contrast,              membrane. Instead, TOR2-3XGFP detectable TOR2N321-3XGFP functional  Fig. S3 supple-             background punctate structures. structures mental material). Nineteen 23 dissected tetrads                apparent beneath plasma membrane.
TOR2N321-3XGFP produced viable spores. expected                  better resolve structures, used confocal micros-
diagnostic PCR product (441 nt) observed 2:2                 copy (Fig. 10; Fig. S4 supplemental material).
segregation tetrads analyzed, product             TOR2-3XGFP signal cytoplasmic concentrated absent control cells (Fig. 8A).                                    punctate structures near plasma membrane.
  441-nt product expected reverse primer         TOR1-3XGFP cytoplasmic concentrated near vac-
amplifying closest site GFP sequence.          uole. identities TOR structures near plasma assess  performed colony PCR primers           membrane unknown, resemble eisosomes chosen close flanking N321 site (Fig. 8B).             location appearance numerous eiso-
 VOL. 7, 2008                                                                                      TOR1-3XGFP TOR2-3XGFP                 1827




   FIG. 8. TOR2 functional N321 replaced 1X-, 2X-, 3XGFP.   441-nt product (asterisk) establishes insertion GFP germinated spores 2:2 segregation  text). Primers TOR2/â«¹711 GFP/Rev spores 2A 2D (template) used colony  1 (TB50a/â?£ background). (B) Results PCR consistent 2XGFP replacing N321 recombination event JK9 colony  1, 1XGFP TB50 colony  2, 3XGFP TB50 colony  1  text). Primers TOR2/Fwd/â«¹931 TOR2/Rev/â«¹990 used. templates
used follows: 2XGFP-JK9 lanes, 2A, 2B,  20C; 1XGFP-TB50 lanes, 18A, 18B, 20A, 20B (colony  2); 3XGFP-TB50
lanes, 2A, 2B, 7C, 7D (colony  1). Arrows indicate diagnostic bands 1X-, 2X-, 3XGFP  text). (C) Western blot anti-GFP 40 â?®g lysate protein  Materials Methods) control (Ctl), TB50a, VA102 strains.



somes. Eisosomes recently defined character-                 functional tagged proteins complementary imag-
ized punctate structures plasma membrane involved                ing proteins fixed cells antibodies. Fixation cause early steps endocytosis (36, 39).                                loss vesicular localization proteins, example, Rheb
                                                                           (34). various localization patterns TORs provide                                                                            molecular basis large number processes controlled                           DISCUSSION
                                                                           TOR explain different studies observed
  constructed functional TOR1-3XGFP TOR2-                           TOR different cellular locations. localization TOR 3XGFP proteins localize TOR living cells. Importantly,               mammals ambiguous, possibly mTOR required insertion GFP TOR1 TOR2                 known literature FRAP [FKBP12-rapamycin-asso-
ORFs N C terminus. TOR1-3XGFP                    ciated protein[) different locations. mTOR cytoplasmic concentrated prevacuolar compartment                  reported principally cytoplasmic shuttle vacuolar membrane. TOR2-3XGFP cyto-                    cytoplasm nucleus (20), principally
plasmic  strikingly, concentrated plasma mem-              nuclear cancer cell lines (42), cytoplasmic brane. did detectably observe TOR1-3XGFP                     associated Golgi bodies ER (26), asso-
nucleus, nucleus qualitatively correlated               ciated regulatory subunit protein kinase (RIâ?£) decreased staining versus surrounding cytoplasm (data              late endosomes autophagosomes (30). study
shown). studies required address  Imaging             used GFP-tagged mTOR, GFP-tagged mTOR 
 1828     STURGILL ET AL.                                                                                                 EUKARYOT. CELL




   FIG. 9. TOR2N321-3XGFP localizes punctate structures near plasma membrane. performed microscopy following strains SD SD-leu  : TB50a (control strain, SD), TOR1-3XGFP (V102, SD), TOR1-3XGFP plus FYVE-dsRed (VA102
transformed pTPQ127, SD-leu), TOR2-3XGFP plus Sec7-dsRed (VA102 transformed pTPQ128, SD-leu). VA102 strain
lost pSH47 (URA3) plasmid 5-fluoroorotic acid treatment (Table 3).


expressed N terminally tagged 1XGFP func-             plicated endocytosis actin dynamics (14). Furthermore,
tionality remains established.                                   TOR2 activates AGC family kinase Ypk2 (17). Ypk2 phos-
   concentration TOR1-3XGFP near vacuolar                   phorylates Pil1 Lsp1, proteins involved eisosome 
membrane consistent reports literature.            mation function (29).  TORC2 required loss TOR1 synthetically lethal loss class C VPS      sphingolipid biosynthesis (4) Ypk2 activated (vacuolar protein sorting) genes (43). genetic interaction        sphingolipids  review, reference 25). findings likely specific TOR1 overexpression TOR2          make eisosomes interesting candidate location fails rescue synthetic lethality. second correlation,      TOR2 plasma membrane. attempted address TOR1 interactors Kog1 Tco89 detected near             introducing mCherry tag C terminus LSP1 vacuolar membrane imaging Kog1-GFP live cells           SUR7 TOR2-3XGFP strain   Lsp1
immunogold staining Tco89 fixed cells (2, 32, 37).           Sur7 mCherry signals brighter cause strain differences affect TOR1-related phenotypes            TOR2-3XGFP signal (ii) TOR2-3XGFP signal showed
(9, 32), confirmed Kog1-8XGFP concentrated            partial colocalization markers (data shown). vacuolar membrane TB50  supplemental                 Avo3 shows partial colocalization Pil1  eisosome
material). correlation, TOR1 interacts genetically          marker) immunofluorescence fixed cells (R. Shioda,  biochemically Gtr2 Ego complex, near             published data). specific localization TOR2-3XGFP vacuolar membrane (12). Finally, phosphorylation            eisosomes remains defined.
Sch9 TORC1 occur near vacuole Sch9                     findings provide insight structure TOR. localizes near organelle artificial Sch9 substrate         remarkable TOR, strongly conserved protein â¬ƒ2,500
tethered vacuolar membrane phosphorylated               amino acids, retains partial function insertion
TORC1-dependent manner (37). connection               748 amino acids (3XGFP cassette) noncatalytic 
TORC1 vacuole, derive role               main. functionality internally tagged TOR1-3XGFP
vacuole nutrient supply regulation autophagy (19).            TOR2-3XGFP proteins placement physiological relevance TOR1 cytoplasm         3XGFP subdomains. majority N terminus
plasma membrane remains determined.                         TOR consists repeated HEAT motifs (21). D330    localization TOR2-3XGFP discrete sites near           N321 gap HEAT repeats  Fig. S5 plasma membrane similar eisosomes, recently              supplemental material). Furthermore, recent electron mi-
described protein complexes important endocytosis (39).         croscopy structure TOR1 suggests noncatalytic 
Interestingly, TOR2 mainly TORC2, im-             main forms N-terminal head, turn, arm (1).  VOL. 7, 2008                                                                                                   TOR1-3XGFP TOR2-3XGFP                          1829

                                                                                    4. Aronova, S., K. Wedaman, P.  Aronov, K. Fontes, K. Ramos, B. D. Ham-
                                                                                       mock, T. Powers. 2008. Regulation ceramide biosynthesis TOR
                                                                                       complex 2. Cell Metab. 7:148â€“158.
                                                                                    5. Cardenas, M. E., J. Heitman. 1995. FKBP12-rapamycin target TOR2                                                                                        vacuolar protein associated phosphatidylinositol-4 kinase activity.
                                                                                       EMBO J. 14:5892â€“5907.
                                                                                    6. Cohen, , N. Perzov, H. Nelson, N. Nelson. 1999. novel family yeast
                                                                                       chaperons involved distribution V-ATPase membrane
                                                                                       proteins. J. Biol. Chem. 274:26885â€“26893.
                                                                                    7. Combet, C., C. Blanchet, C. Geourjon, G. Deleage. 2000. NPS@: net-
                                                                                       work protein sequence analysis. Trends Biochem. Sci. 25:147â€“150.
                                                                                    8. Deitz, S. B.,  Rambourg, F. Kepes,  Franzusoff. 2000. Sec7p directs
                                                                                       transitions required yeast Golgi biogenesis. Traffic (Copenhagen)
                                                                                       1:172â€“183.
                                                                                    9. Devasahayam, G., D. J. Burke, T. W. Sturgill. 2007. Golgi manganese
                                                                                       transport required rapamycin signaling Saccharomyces cerevisiae.
                                                                                       Genetics 177:231â€“238.
                                                                                   10. Devasahayam, G., D. Ritz, S. B. Helliwell, D. J. Burke, T. W. Sturgill.
                                                                                       2006. Pmr1, Golgi Ca2â«¹/Mn2â«¹-ATPase, regulator target                                                                                        rapamycin (TOR) signaling pathway yeast. Proc. Natl. Acad. Sci. USA
                                                                                       103:17840â€“17845.
                                                                                   11. Virgilio, C., R. Loewith. 2006. Cell growth control: little eukaryotes
                                                                                       make big contributions. Oncogene 25:6392â€“6415.
                                                                                   12. Dubouloz, F., O. Deloche, V. Wanke, E. Cameroni, C. Virgilio. 2005.
                                                                                       TOR EGO protein complexes orchestrate microautophagy yeast.
                                                                                       Mol. Cell 19:15â€“26.
                                                                                   13. Durr, G., J. Strayle, R. Plemper, S. Elbs, S. K. Klee, P. Catty, D. H. Wolf,                                                                                        H. K. Rudolph. 1998. medial-Golgi ion pump Pmr1 supplies yeast
                                                                                       secretory pathway Ca2â«¹ Mn2â«¹ required glycosylation, sorting,
                                                                                       endoplasmic reticulum-associated protein degradation. Mol. Biol. Cell
                                                                                       9:1149â€“1162.
                                                                                   14. Fadri, M.,  Daquinag, S. Wang, T. Xue, J. Kunz. 2005. pleckstrin
                                                                                       homology domain proteins Slm1 Slm2 required actin cytoskele-
                                                                                       ton organization yeast bind phosphatidylinositol-4,5-bisphosphate                                                                                        TORC2. Mol. Biol. Cell 16:1883â€“1900.
                                                                                   15. Gauss, R., M. Trautwein, T. Sommer,  Spang. 2005. New modules                                                                                        repeated internal N-terminal epitope tagging genes Saccharo-
                                                                                       myces cerevisiae. Yeast (Chichester) 22:1â€“12.
                                                                                   16. Guldener, U., S. Heck, T. Fielder, J. Beinhauer, J. H. Hegemann. 1996.
                                                                                       new efficient gene disruption cassette repeated use budding yeast.
                                                                                       Nucleic Acids Res. 24:2519â€“2524.
   FIG. 10. TOR1 TOR2 distinct localization patterns                   17. Kamada, Y., Y. Fujioka, N. N. Suzuki, F. Inagaki, S. Wullschleger, R.
confocal microscopy. control (TB50), TOR1-3XGFP (VA66),                        Loewith, M. N. Hall, Y. Ohsumi. 2005. Tor2 directly phosphorylates TOR2-3XGFP strains grown YPD imaged confocal micros-                        AGC kinase Ypk2 regulate actin polarization. Mol. Cell. Biol. 25:7239â€“
copy  Materials Methods). exposure settings used                   7248.
follows: Tor1, 400 ms GFP 50  laser intensity; Tor2, 800 ms GFP                18. Katzmann, D. J., S. Sarkar, T. Chu,  Audhya, S. D. Emr. 2004. 70  laser intensity; TB50, 800 ms GFP 70  laser inten-                     Multivesicular body sorting: ubiquitin ligase Rsp5 required modi-
sity.                                                                                  fication sorting carboxypeptidase S. Mol. Biol. Cell 15:468â€“480.
                                                                                   19. Khalfan, W. , D. J. Klionsky. 2002. Molecular machinery required                                                                                        autophagy cytoplasm vacuole targeting (Cvt) pathway S. cer-
                                                                                       evisiae. Curr. Opin. Cell Biol. 14:468â€“475.
predict D330 N321 near gap                           20. Kim, J. E., J. Chen. 2000. Cytoplasmic-nuclear shuttling FKBP12-
                                                                                       rapamycin-associated protein involved rapamycin-sensitive signaling subdomains. preservation function internal                           translation initiation. Proc. Natl. Acad. Sci. USA 97:14340â€“14345.
tagging TOR GFP fact                       21. Kunz, J., U. Schneider,  Howald,  Schmidt, M. N. Hall. 2000. HEAT
N terminus C terminus GFP near                               repeats mediate plasma membrane localization Tor2p yeast. J. Biol.
                                                                                       Chem. 275:37011â€“37020.
 Protein Data Bank entry 1EMM), minimizing displace-                           22. Lee, W. L., J. R. Oberle, J.  Cooper. 2003. role lissencephaly
ment point insertion.                                                        protein Pac1 nuclear migration budding yeast. J. Cell Biol. 160:
                                                                                       355â€“364.
                                                                                   23. Lemmon, M.  2003. Phosphoinositide recognition domains. Traffic  
                         ACKNOWLEDGMENTS                                               penhagen) 4:201â€“213.
                                                                                   24. Li, H., C. K. Tsang, M. Watkins, P. G. Bertram, X. F. Zheng. 2006.
  thank colleagues Spang Hall laboratories                 Nutrient regulates Tor1 nuclear localization association rDNA
help. thank Christiana Walch-Solimena Yukifumi Uesonso                      promoter. Nature 442:1058â€“1061.
important reagents.                                                                25. Liu, K., X. Zhang, C. Sumanasekera, R. L. Lester, R. C. Dickson. 2005.
  research supported Swiss National Science Foun-                      Signalling functions sphingolipid long-chain bases Saccharomyces
dation Canton Basel (M.N.H.) National Insti-                     cerevisiae. Biochem. Soc. Trans. 33:1170â€“1173.
tutes Health (DK052753) (T.W.S.).                                               26. Liu, X., X. F. Zheng. 2007. Endoplasmic reticulum Golgi localiza-
                                                                                       tion sequences mammalian target rapamycin. Mol. Biol. Cell 18:1073â€“
                                                                                       1082.
                                REFERENCES                                         27. Loewith, R., E. Jacinto, S. Wullschleger,  Lorberg, J. L. Crespo, D. Bonen-
 1. Adami, , B. Garcia-Alvarez, E. Arias-Palomo, D. Barford, O. Llorca.          fant, W. Oppliger, P. Jenoe, M. N. Hall. 2002. TOR complexes,     2007. Structure TOR complex KOG1. Mol. Cell 27:509â€“516.            rapamycin sensitive, distinct roles cell growth control.
 2. Araki, T., Y. Uesono, T. Oguchi, E.  Toh. 2005. LAS24/KOG1,                Mol. Cell 10:457â€“468.
    component TOR complex 1 (TORC1), needed resistance            28. Losev, E., C.  Reinke, J. Jellen, D. E. Strongin, B. J. Bevis, B. S. Glick.
    local anesthetic tetracaine normal distribution actin cytoskeleton       2006. Golgi maturation visualized living yeast. Nature 441:1002â€“1006.
    yeast. Genes Genet. Syst. 80:325â€“343.                                          29. Luo, G.,  Gruhler, Y. Liu, O. N. Jensen, R. C. Dickson. 2008.  3. Aronova, S., K. Wedaman, S. Anderson, J. Yates III, T. Powers. 2007.           sphingolipid long-chain base-Pkh1/2-Ypk1/2 signaling pathway regulates
    Probing membrane environment TOR kinases reveals functional             eisosome assembly turnover. J. Biol. Chem. 283:10433â€“10444.
    interactions TORC1, actin, membrane trafficking Saccharo-       30. Mavrakis, M., J. Lippincott-Schwartz, C.  Stratakis,  Bossis. 2007.
    myces cerevisiae. Mol. Biol. Cell 18:2779â€“2794.                                    mTOR kinase regulatory subunit protein kinase (PRKAR1A)
 1830         STURGILL ET AL.                                                